{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:17:34Z","timestamp":1790615854959,"version":"4.1.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpsychires.2026.06.035","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:27:53Z","timestamp":1782257273000},"page":"418-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6543-481X","authenticated-orcid":false,"given":"J\u00falio C\u00e9sar","family":"Claudino dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia Janu\u00e1rio","family":"Bolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Lodetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germano Lapa","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Pacheco","family":"Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinara Ludvig","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.035_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.15537\/smj.2025.46.3.20240788","article-title":"Effectiveness of social skills training interventions for children with autism spectrum disorder: a systematic review and meta-analysis","volume":"46","author":"Alahmari","year":"2025","journal-title":"Saudi Med. J."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.035_bib3","first-page":"318","article-title":"Risperidone or aripiprazole can resolve autism core signs and symptoms in young children: case study","volume":"8","author":"Alsayouf","year":"2021","journal-title":"Children (Basel, Switzerland)"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00787-025-02697-7","article-title":"Effects of social skills training on social responsiveness of people with Autism spectrum disorder: a systematic review with meta-analysis","volume":"34","author":"Anchieta","year":"2025","journal-title":"Eur. Child Adolesc. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.06.035_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.49026","article-title":"Psilocybin therapy for Clinicians with symptoms of depression from frontline care during the COVID-19 pandemic: a randomized clinical trial","volume":"7","author":"Back","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11673-024-10386-4","article-title":"History, hype, and responsible psychedelic medicine: a qualitative Study of psychedelic researchers","volume":"22","author":"Barber","year":"2025","journal-title":"J. bioeth. Inq."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-5380-1-9","article-title":"Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression","volume":"1","author":"Belzung","year":"2011","journal-title":"Biol. Mood Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13229-021-00418-w","article-title":"Modified CBT for social anxiety and social functioning in young adults with autism spectrum disorder","volume":"12","author":"Bemmer","year":"2021","journal-title":"Mol. Autism"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.035_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/02698811231224153","article-title":"MDMA enhances positive affective responses to social feedback","volume":"38","author":"Bershad","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.06.035_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/psymed.2023.0007","article-title":"A systematic review of reporting practices in psychedelic clinical trials: psychological support, therapy, and psychosocial interventions","volume":"1","author":"Brennan","year":"2023","journal-title":"Psychedelic medicine (New Rochelle, N.Y.)"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neubiorev.2008.09.002","article-title":"Default-mode brain dysfunction in mental disorders: a systematic review","volume":"33","author":"Broyd","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"45","key":"10.1016\/j.jpsychires.2026.06.035_bib17","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1523\/JNEUROSCI.1384-23.2023","article-title":"Beyond the 5-HT2A receptor: classic and nonclassic targets in psychedelic drug action","volume":"43","author":"Cameron","year":"2023","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib24","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1017\/S0033291715002901","article-title":"The paradoxical psychological effects of lysergic acid diethylamide (LSD)","volume":"46","author":"Carhart-Harris","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fmri-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnint.2013.00025","article-title":"Serotonin modulation of cortical neurons and networks","volume":"7","author":"Celada","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib27","article-title":"Psychedelics and neurodevelopmental disorders: preclinical models and translational challenges","author":"Chaliha","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jad.2018.09.076","article-title":"Abnormal cerebellum-DMN regions connectivity in unmedicated bipolar II disorder","volume":"243","author":"Chen","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/JCMA.0000000000001150","article-title":"Autism, youth suicide, and psychedelics: a review of the 21st century evidence","volume":"87","author":"Chen","year":"2024","journal-title":"J. Chin. Med. Assoc."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13229-024-00585-6","article-title":"Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment","volume":"15","author":"Choi","year":"2024","journal-title":"Mol. Autism"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib31","first-page":"29","article-title":"Behavioral interventions for autism spectrum disorder: a brief review and guidelines with a specific focus on applied behavior analysis","volume":"35","author":"Chung","year":"2024","journal-title":"Journal of the Korean Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s40489-025-00506-0","article-title":"A meta-analysis of applied behavior analysis-based interventions to improve communication, adaptive, and cognitive skills in children on the autism spectrum","author":"Collins","year":"2025","journal-title":"Rev J Autism Dev Disord"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib33","article-title":"Signs and symptoms of autism spectrum disorder and early diagnosis as a benefit in the prognosis of pediatric patients: a systematic review","author":"Da Silva","year":"2023","journal-title":"International Seven Journal of Health Research"},{"issue":"11","key":"10.1016\/j.jpsychires.2026.06.035_bib34","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","article-title":"Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study","volume":"235","author":"Danforth","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2026.06.035_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/cap.2023.0065","article-title":"Long-term effectiveness of off-label risperidone treatment in children and adolescents: a randomized, placebo-controlled discontinuation study","volume":"34","author":"Dinnissen","year":"2024","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"7466","key":"10.1016\/j.jpsychires.2026.06.035_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature12518","article-title":"Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin","volume":"501","author":"D\u00f6len","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10803-022-05431-3","article-title":"Occupational therapy interventions using new technologies in children and adolescents with autism spectrum disorder: a scoping review","volume":"53","author":"Dom\u00ednguez-Lucio","year":"2023","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/2045125316638008","article-title":"Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years","volume":"6","author":"Dos Santos","year":"2016","journal-title":"Ther Adv Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s40359-024-02045-5","article-title":"The effectiveness of applied behavior analysis program training on enhancing autistic children's emotional-social skills","volume":"12","author":"Du","year":"2024","journal-title":"BMC Psychol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib43","article-title":"Navigating the chaos of psychedelic neuroimaging: a multi-metric evaluation of acute psilocybin effects on brain entropy","author":"E-Wen McCulloch","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s44271-023-00012-1","article-title":"Psychedelics reopening windows of development in mice","author":"Eisenkoeck","year":"2023","journal-title":"Communications Psychology"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00304","article-title":"Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder","volume":"12","author":"Eissa","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib47","article-title":"Cellular rules underlying psychedelic control of prefrontal pyramidal neurons","volume":"10.20","author":"Ekins","year":"2023","journal-title":"bioRxiv : the preprint server for biology"},{"issue":"9","key":"10.1016\/j.jpsychires.2026.06.035_bib48","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/02698811251338214","article-title":"Set and setting of psychedelics for therapeutic use in psychiatry: a systematic review","volume":"39","author":"Estric","year":"2025","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.06.035_bib49","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41386-025-02091-6","article-title":"Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression","volume":"50","author":"Falchi-Carvalho","year":"2025","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jpsychires.2026.06.035_bib50","article-title":"Early speech therapy intervention in children with Autism Spectrum Disorder","volume":"37","author":"Ferreira","year":"2025","journal-title":"Interven\u00e7\u00e3o precoce fonoaudiol\u00f3gica em crian\u00e7as com Transtorno do Espectro Autista. CoDAS"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neubiorev.2021.07.014","article-title":"The neuropathology of autism: a systematic review of post-mortem studies of autism and related disorders","volume":"129","author":"Fetit","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmjebm-2021-111804","article-title":"Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews","volume":"28","author":"Fieiras","year":"2023","journal-title":"BMJ Evid.-Based Med."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib54","series-title":"Autism. Routledge, 2nd Edition. | Milton Park, Abingdon, Oxon ; New York, NY : Routledge","author":"Fletcher-Watson","year":"2019"},{"issue":"122","key":"10.1016\/j.jpsychires.2026.06.035_bib55","first-page":"41407","article-title":"Psychedelic drugs: considerations for clinical investigations; draft guidance for industry; availability","volume":"88","year":"2023","journal-title":"Fed. Regist."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib57","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","article-title":"Oxidative stress-related biomarkers in autism: systematic review and meta-analyses","volume":"52","author":"Frustaci","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106520","article-title":"Biomarkers of mitochondrial dysfunction in autism spectrum disorder: a systematic review and meta-analysis","volume":"197","author":"Frye","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.06.035_bib59","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/brainsci10060368","article-title":"The effects of the early start Denver model for children with autism spectrum disorder: a meta-analysis","volume":"10","author":"Fuller","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib60","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1038\/s41598-018-26656-2","article-title":"Psilocybin and MDMA reduce costly punishment in the ultimatum game","volume":"8","author":"Gabay","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jpsychires.2026.06.035_bib61","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s00787-023-02138-3","article-title":"miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis","volume":"33","author":"Garrido-Torres","year":"2024","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","article-title":"Default mode network modulation by psychedelics: a systematic review","volume":"26","author":"Gattuso","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib64","first-page":"536","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"315","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib65","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.biopsych.2006.09.020","article-title":"Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus","volume":"62","author":"Greicius","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"45","key":"10.1016\/j.jpsychires.2026.06.035_bib66","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1523\/JNEUROSCI.1121-22.2022","article-title":"Psychedelics and neural plasticity: therapeutic implications","volume":"42","author":"Grieco","year":"2022","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"issue":"12","key":"10.1016\/j.jpsychires.2026.06.035_bib67","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pnpbp.2013.01.010","article-title":"Abnormal resting-state cerebellar\u2013cerebral functional connectivity in treatment-resistant depression and treatment sensitive depression","volume":"44","author":"Guo","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2026.06.035_bib69","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3390\/brainsci15121280","article-title":"A review of therapeutic approaches for autism spectrum disorder","volume":"15","author":"Hai","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115531","article-title":"Psilocybin-assisted therapy for depression: a systematic review and meta-analysis","volume":"329","author":"Haikazian","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib73","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12887-025-05832-0","article-title":"Efficacy of physiotherapy with occupational and speech therapy for improving physical & behavioral status among children with autism spectrum disorder (ASD): an assessor blinded randomized clinical trial","volume":"25","author":"Haque","year":"2025","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib74","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1007\/s10803-019-04087-w","article-title":"Empathy in autism spectrum disorder","volume":"49","author":"Harmsen","year":"2019","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib75","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tics.2013.10.016","article-title":"Hierarchical modular brain connectivity is a stretch for criticality","volume":"18","author":"Hilgetag","year":"2014","journal-title":"Trends Cognit. Sci."},{"issue":"8","key":"10.1016\/j.jpsychires.2026.06.035_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270833","article-title":"Intensive behavioural interventions based on applied behaviour analysis (ABA) for young children with autism: a cost-effectiveness analysis","volume":"17","author":"Hodgson","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.035_bib78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib79","doi-asserted-by":"crossref","DOI":"10.1007\/s10802-018-0402-1","article-title":"Prevalence of depressive disorders in individuals with autism spectrum disorder: a meta-analysis","author":"Hudson","year":"2019","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2016.00205","article-title":"Resting-state functional connectivity in autism spectrum disorders: a review","volume":"7","author":"Hull","year":"2017","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib81","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ijnp\/pyz029","article-title":"Motives and side-effects of microdosing with psychedelics among users","volume":"22","author":"Hutten","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.035_bib82","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/02698811251319457","article-title":"Single-dose psilocybin therapy for alcohol use disorder: pharmacokinetics, feasibility, safety and efficacy in an open-label study","volume":"39","author":"Jensen","year":"2025","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.jpsychires.2026.06.035_bib83","first-page":"1272","article-title":"A longitudinal transdisciplinary approach for autism spectrum disorder","volume":"12","author":"Kabarite","year":"2025","journal-title":"Children (Basel, Switzerland)"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","article-title":"The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals","volume":"57","author":"Kamilar-Britt","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1582354","article-title":"rTMS-induced neuroimaging changes measured with structural and functional MRI in autism","volume":"19","author":"Kang","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib86","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/psymed.2023.0023","article-title":"Balancing therapeutic efficacy and safety of MDMA and novel MDXX analogues as novel treatments for autism spectrum disorder","volume":"1","author":"Kaur","year":"2023","journal-title":"Psychedelic Medicine"},{"issue":"7","key":"10.1016\/j.jpsychires.2026.06.035_bib87","article-title":"Emerging treatments and therapies for autism spectrum disorder: a narrative review","volume":"16","author":"Kaye","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib88","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1016\/j.cub.2021.12.009","article-title":"Psychedelics","volume":"32","author":"Kelmendi","year":"2022","journal-title":"Curr. Biol."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.06.035_bib90","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/15374416.2020.1833735","article-title":"Predictors and moderators of treatment efficacy in children and adolescents with autism spectrum disorder","volume":"50","author":"Klinger","year":"2021","journal-title":"J. Clin. Child Adolesc. Psychol. : the official journal for the Society of Clinical Child and Adolescent Psychology"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib91","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopsych.2010.10.002","article-title":"The 5-HT2A\/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations","volume":"69","author":"Kometer","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib92","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.035_bib93","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/acps.13587","article-title":"Systematic review: autism spectrum disorder and the gut microbiota","volume":"148","author":"Korteniemi","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib94","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib95","doi-asserted-by":"crossref","first-page":"pyaf022","DOI":"10.1093\/ijnp\/pyaf022","article-title":"Premorbid characteristics of the SAPAP3 mouse model of obsessive-compulsive disorder: behavior, neuroplasticity, and psilocybin treatment","volume":"28","author":"Lazar","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib96","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/hbm.22833","article-title":"Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin","volume":"36","author":"Lebedev","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib97","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.3390\/ijms23126515","article-title":"Serotonin receptors as therapeutic targets for autism spectrum disorder treatment","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.035_bib98","first-page":"367","article-title":"Psychedelics and evidence-based psychotherapy","volume":"47","author":"Leone","year":"2024","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib101","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuro.2022.05.008","article-title":"Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats","volume":"91","author":"Liu","year":"2022","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111129","article-title":"Classic psychedelics and the treatment for alcoholism","volume":"135","author":"Lodetti","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib103","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41380-018-0321-0","article-title":"Big data approaches to decomposing heterogeneity across the autism spectrum","volume":"24","author":"Lombardo","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"Lord","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib105","article-title":"Autism early intervention providers: their priorities, use of empirically supported practices, and professional development needs","author":"Luskin Saxby","year":"2025","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib106","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.euroneuro.2021.06.001","article-title":"Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience","volume":"50","author":"Madsen","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/aur.3312","article-title":"Expanding research on contextual factors in autism research: what took us So long?","author":"Mailick","year":"2025","journal-title":"Autism Res. : Official Journal Of The International Society For Autism Research"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib110","first-page":"122","article-title":"Importance of early intervention in reducing autistic symptoms and speech-language deficits in children with autism spectrum disorder","volume":"10","author":"Maksimovi\u0107","year":"2023","journal-title":"Children (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-024-03814-0","article-title":"Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms","volume":"23","author":"Manter","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.749068","article-title":"Evaluating the potential use of serotonergic psychedelics in autism spectrum disorder","volume":"12","author":"Markopoulos","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2019.04.037","article-title":"The influence of neuroinflammation in autism spectrum disorder","volume":"79","author":"Matta","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.06.035_bib116","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib117","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1176\/appi.focus.23021011","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"21","author":"Mitchell","year":"2023","journal-title":"Focus"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2011.12.010","article-title":"The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies","author":"Modi","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib119","doi-asserted-by":"crossref","DOI":"10.1097\/WNF.0000000000000653","article-title":"Psilocybin use in the autism spectrum disorder: a scoping review","author":"Moreno-Chaparro","year":"2025","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.06.035_bib120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamapsychiatry.2025.0044","article-title":"Safety and efficacy of repeated low-dose LSD for ADHD treatment in adults: a randomized clinical trial","volume":"82","author":"Mueller","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib121","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","article-title":"The serotonin system in autism spectrum disorder: from biomarker to animal models","volume":"321","author":"Muller","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1075-9","article-title":"Oxytocin-dependent reopening of a social reward learning critical period with MDMA","author":"Nardou","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib123","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib125","series-title":"Emerging Neurobiology of Antidepressant Treatments. Current Topics in Behavioral Neurosciences 66","article-title":"Psilocybin and other classic psychedelics in depression","author":"Nutt","year":"2023"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2020.2171","article-title":"The current status of psychedelics in psychiatry","volume":"78","author":"Nutt","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106589","article-title":"TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology","volume":"26","author":"Ort","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by Ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib129","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.0873","article-title":"Homological scaffolds of brain functional networks","volume":"11","author":"Petri","year":"2014","journal-title":"J. R. Soc., Interface"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib130","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70020","article-title":"Serotonergic psychedelics rapidly modulate evoked glutamate release in cultured cortical neurons","volume":"169","author":"Petru\u0161kov\u00e1","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib131","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.schres.2024.07.007","article-title":"Aripiprazole dose associations with metabolic adverse effect: results from a longitudinal study","volume":"270","author":"Piras","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib132","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","article-title":"Effect of psilocybin on empathy and moral decision-making","volume":"20","author":"Pokorny","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib134","author":"Poppe"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib135","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-Induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib136","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","article-title":"Psilocybin induces time-dependent changes in global functional connectivity","volume":"88","author":"Preller","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib137","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cercor\/13.8.870","article-title":"In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents","volume":"13","author":"Puig","year":"2003","journal-title":"Cerebr. Cortex"},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.035_bib138","article-title":"Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD)","volume":"2018","author":"Reichow","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib139","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl6554","article-title":"MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbens","volume":"10","author":"Rein","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96736-3","article-title":"LSD-stimulated behaviors in mice require \u03b2-arrestin 2 but not \u03b2-arrestin 1","volume":"11","author":"Rodriguiz","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib141","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib142","article-title":"Autism intervention meta-analysis of early childhood studies (Project AIM): updated systematic review and secondary analysis","volume":"383","author":"Sandbank","year":"2023","journal-title":"BMJ (Clinical research ed.)"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib143","article-title":"Novel therapeutics in autism spectrum disorder","volume":"23","author":"Sara","year":"2026","journal-title":"Neurotherapeutics : The Journal Of The American Society For Experimental Neurotherapeutics"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib144","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1017\/S1092852924002268","article-title":"The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges","volume":"29","author":"Scala","year":"2024","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1193166","article-title":"Editorial: pathway of care and gaps in services for children and adults with autism spectrum disorder","volume":"14","author":"Scattoni","year":"2023","journal-title":"Front. Psychiatr."},{"issue":"9","key":"10.1016\/j.jpsychires.2026.06.035_bib147","article-title":"Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases","volume":"2024","author":"Schipper","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.035_bib148","first-page":"490","article-title":"Altered states and social bonds: effects of MDMA and serotonergic psychedelics on social behavior as a mechanism underlying substance-assisted therapy","volume":"9","author":"Schmid","year":"2024","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"8","key":"10.1016\/j.jpsychires.2026.06.035_bib150","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae083","article-title":"Potential differences in psychedelic actions based on biological sex","volume":"165","author":"Shadani","year":"2024","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jpsychires.2026.06.035_bib151","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/13623613221121425","article-title":"Concomitant medication use in children with autism spectrum disorder: data from the Autism biomarkers consortium for clinical trials","volume":"27","author":"Shurtz","year":"2023","journal-title":"Autism : Int. J. Radiat. Phys."},{"issue":"7","key":"10.1016\/j.jpsychires.2026.06.035_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307491","article-title":"Investigating the impact of psychedelic drugs on social cognition defects: a scoping review protocol","volume":"19","author":"Smith","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109165","article-title":"Novel ethical and policy issues in psychiatric uses of psychedelic substances","volume":"216","author":"Smith","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105325","article-title":"The relationship between the default mode network and the theory of mind network as revealed by psychedelics \u2013 a meta-analysis","volume":"152","author":"Soares","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib156","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cpet.2024.09.010","article-title":"Potential neuroimaging biomarkers for autism spectrum disorder: a comprehensive review of MR imaging, fMR imaging, and PET studies","volume":"20","author":"Subtirelu","year":"2025","journal-title":"Pet. Clin."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib157","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","article-title":"Increased global functional connectivity correlates with LSD-induced ego dissolution","volume":"26","author":"Tagliazucchi","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib158","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neubiorev.2019.04.012","article-title":"Behavioral neuroscience of autism","volume":"110","author":"Takumi","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2013.00458","article-title":"Reconceptualizing functional brain connectivity in autism from a developmental perspective","volume":"7","author":"Uddin","year":"2013","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib160","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1037\/a0037665","article-title":"Precise minds in uncertain worlds: predictive coding in autism","volume":"121","author":"Van de Cruys","year":"2014","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib161","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10803-017-3065-9","article-title":"A predictive coding account of psychotic symptoms in autism spectrum disorder","volume":"47","author":"Van Schalkwyk","year":"2017","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib162","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1512818","article-title":"Proximity-based solutions for optimizing autism spectrum disorder treatment: integrating clinical and process data for personalized care","volume":"15","author":"Vignapiano","year":"2025","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib165","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib166","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41386-021-01091-6","article-title":"Systemic enhancement of serotonin signaling reverses social deficits in multiple mouse models for ASD","volume":"46","author":"Walsh","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib167","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-024-05768-2","article-title":"The \u201cPSILAUT\u201d protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin","author":"Whelan","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.035_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75706-1","article-title":"MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study","volume":"10","author":"Wolfson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib170","doi-asserted-by":"crossref","DOI":"10.1177\/02698811221092509","article-title":"Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: a randomised placebo-controlled single-dose crossover trial","author":"Wong","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"13","key":"10.1016\/j.jpsychires.2026.06.035_bib169","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/s41386-020-0693-0","article-title":"Serotonin differentially modulates the temporal dynamics of the limbic response to facial emotions in male adults with and without autism spectrum disorder (ASD): a randomised placebo-controlled single-dose crossover trial","volume":"45","author":"Wong","year":"2020","journal-title":"Neuropsychopharmacology : Official Publication Of The American College Of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2026.06.035_bib171","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2023.10.008","article-title":"Cognitive behavioural therapy to improve social skills in children and adolescents with autism spectrum disorder: a meta-analysis of randomised controlled trials","volume":"344","author":"You","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib172","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/s41598-023-28111-3","article-title":"From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)","volume":"15","author":"Zeifman","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2026.06.035_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116287","article-title":"Rumination and the default mode network: meta-analysis of brain imaging studies and implications for depression","volume":"206","author":"Zhou","year":"2020","journal-title":"Neuroimage"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626003432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626003432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:34:31Z","timestamp":1790613271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626003432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":149,"alternative-id":["S0022395626003432"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.06.035","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}